Myeloid leukemia is a type of blood cancer that originates in the bone marrow, where blood cells are produced. It is characterized by the uncontrolled growth of abnormal white blood cells, known as myeloid cells. These cells typically fail to mature properly, leading to an accumulation of immature or dysfunctional cells that crowd out normal blood cells, impairing the body's ability to fight infections, transport oxygen, and prevent bleeding.
Myeloid Leukemia is a type of blood cancer that begins in the bone marrow, where blood cells are produced. It primarily affects the myeloid cells, which are responsible for the development of red blood cells, white blood cells, and platelets. There are different forms of myeloid leukemia, each with unique characteristics.
Dr. Rahul Bhargava and his team provide world-class care and cutting-edge treatment for patients diagnosed with Myeloid Leukemia.
While the exact cause of Myeloid Leukemia is still unknown, several factors have been linked to an increased risk of developing the disease, such as:
There are two primary types of Myeloid Leukemia:
AML is an aggressive form that progresses rapidly and affects the immature blood cells. It requires urgent medical attention and treatment.
CML progresses more slowly and may not show symptoms for a long period. It involves a specific genetic mutation called the Philadelphia chromosome, which leads to uncontrolled growth of abnormal blood cells.
The symptoms of Myeloid Leukemia vary depending on the type (AML or CML) and the stage of the disease. Common symptoms include:
Early diagnosis of Myeloid Leukemia can significantly improve treatment outcomes. Dr. Rahul Bhargava uses a combination of advanced diagnostic techniques to accurately identify the type and stage of leukemia:
Dr. Bhargava and his team ensure a precise and timely diagnosis to guide treatment decisions.
Dr. Rahul Bhargava is a pioneer in providing state-of-the-art treatment for Myeloid Leukemia, including both standard and advanced therapies. Depending on the type and stage of leukemia, the following treatments may be recommended:
The cost of treating Myeloid Leukemia in India is significantly more affordable compared to many Western countries, making it an attractive option for medical tourism. The total cost of treatment, including hospital stay, depends on the type of Myeloid Leukemia, the complexity of treatment, and the duration of care. Below is an overview of the treatment costs in India:
Chemotherapy (per cycle):
USD: $400 – $2,700
INR: ₹30,000 – ₹2,00,000
Radiation Therapy (full course):
USD: $600 – $2,000
INR: ₹50,000 – ₹1,50,000
Targeted Therapy (per month):
USD: $1,300 – $6,500
INR: ₹1,00,000 – ₹5,00,000
Bone Marrow Transplant (Stem Cell Transplant):
USD: $12,000 – $24,000
INR: ₹10,00,000 – ₹20,00,000
Hospital Stay (per night):
USD: $25 – $200
INR: ₹2,000 – ₹15,000 per night
India’s healthcare system offers excellent care at a fraction of the cost found in other countries, making it a cost-effective choice for patients seeking treatment for Myeloid Leukemia. Despite the lower cost, the quality of medical services and expertise remains world-class.